Biopolar Disorder Therapeutics Market 2015 Analysis

Bipolar disorder is a psychological disorder characterized by intermittent mood swings. The individual suffering with this disorder experiences extreme poles of either mania or depression or both. The disorder severely affects the personal, social, and professional life of an individual. The symptoms usually include drastic changes in mood, either as a manic episode or a depressive episode. There is no complete cure for the disorder. Atypical antipsychotics, mood stabilizers, and antidepressants are being widely used in for treatment. It is considered as a lifelong disease and the discontinuation of the medication can lead to relapse of the condition.

Publisher's analysts forecast the global bipolar disorder therapeutics market to grow at a CAGR of 2.24% over the period 2014-2019.

For more information about this report: .

Covered in this report
The report covers the present scenario and growth prospects of the global bipolar disorder therapeutics market for 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of prescription, generic, and off-label drugs used in the treatment of bipolar disorder.

Publisher's report, Global Bipolar Disorder Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, APAC, and EMEA; it also covers the landscape of the global bipolar disorder therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions
- Americas

Key vendors
- Allergan
- AstraZeneca
- Eli Lilly
- GlaxoSmithKline
- Janssen Pharmaceuticals 


Request Sample Copy at .


Other prominent vendors
- AbbVie
- Abital Pharma
- Astellas
- Convergence Pharmaceuticals
- D Pharm
- Delpor
- Gedeon Richter
- H. Lundbeck
- Intra-Cellular Therapies
- Novartis
- Noven Pharmaceuticals
- Omeros Corporation
- Otsuka
- Pfizer
- PNBDevCo
- Reviva Pharmaceuticals 
- SK Biopharmaceuticals
- Sunovion Pharmaceutical 

Key market driver
- Increase in prevalence of bipolar disorder
- For a full, detailed list, view our report

Key market challenge
- Use of alternative therapies
- For a full, detailed list, view our report

Key market trend
- Rise in public awareness
- For a full, detailed list, view our report


Make an enquiry: .

Contact Us:
Call: +1-646-491-9876